Tag: Occupational Hazards

HHS renews COVID-19 public health emergency

Editor's Note Department of Health & Human Services Secretary Alex Azar on January 8 announced the renewal of the COVID-19 national public health emergency declaration, the American Hospital Association reports. The renewal is effective January 21 and will last 90 days. The declaration provides hospitals, health systems, and healthcare workers…

Read More

By: Judy Mathias
January 11, 2021
Share

Ofstead & Associates offering free access to webinars until January 21

Editor's Note Cori L. Ofstead, MSPH, President and CEO of Ofstead & Associates, has announced that Ofstead & Associates is offering all of their webinars for free until January 21. The CE-eligible webinars include: Uncovering device adverse events to improve safety for patients and personnel Respiratory protection: Unmasked. A selection…

Read More

By: Judy Mathias
January 11, 2021
Share

Effect of open schools on child, teacher COVID-19 morbidity in Sweden

Editor's Note In mid-March 2020, when many countries closed schools in an attempt to limit the spread of COVID-19, Sweden decided to keep preschools with children 1-6 years of age and schools with children 7-16 years of age open. In this January 6, 2021, letter to the editor, researchers from…

Read More

By: Judy Mathias
January 7, 2021
Share

Joint Commission issues update on offsite surveys, reviews

Editor's Note The Joint Commission on January 6, 2020, issued an update on offsite surveys and reviews, noting that it had stopped most onsite surveys and reviews from March 16 to May 31, 2020. During that time they developed processes for conducting offsite or virtual events. As of mid-December, more…

Read More

By: Judy Mathias
January 7, 2021
Share

CDC: Allergic reactions after receipt of first dose of Pfizer/BioNTech, Moderna COVID-19 vaccines

Editor's Note From December 14 to December 23, 2020, monitoring by the Center for Disease Control and Prevention’s (CDC’s) Vaccine Adverse Event Reporting System found 4,393 (0.2%) adverse events after administration of 1,893,360 first doses of the Pfizer/BioNTech COVID-19 vaccine. Of these adverse events, 21 were determined to be cases…

Read More

By: Judy Mathias
January 7, 2021
Share

Joint Commission questionnaire identifies COVID-19 impact on organizations

Editor's Note The Joint Commission on January 6, 2021, reported on an online questionnaire sent to organizations in September 2020 to learn about their challenges and needs during the COVID-19 pandemic. A total of 735 respondents, representing a variety of healthcare settings, reported: a medium to high impact on their…

Read More

By: Judy Mathias
January 7, 2021
Share

Risk factors linked to mortality in nursing home residents with COVID-19

Editor’s Note In this study of nursing home residents with COVID-19, increased age, male gender, and impaired cognitive and physical function were independent risk factors for all-cause 30-day mortality. Of 5,256 nursing home residents with COVID-19 in 351 US nursing homes: Odds of death were 1.46 times higher for residents…

Read More

By: Judy Mathias
January 6, 2021
Share

CDC updates number of distributed COVID-19 vaccine doses

Editor’s Note As of January 5, the Centers for Disease Control and Prevention (CDC) reports that the number of distributed COVID-19 vaccines from Pfizer/BioNTech and Moderna is 17,020,575 doses, with 4,836,469 already administered.

Read More

By: Judy Mathias
January 6, 2021
Share

FEMA extends rule limiting exports of scarce PPE

Editor’s Note The Federal Emergency Management Agency (FEMA), on December 31, 2020, posted in the Federal Register that it had extended its temporary final rule, “Prioritization and Allocation of Certain Scarce and Critical Health and Medical Resources for Domestic Use,” with changes, through June 30, 2021. The rule designates certain…

Read More

By: Judy Mathias
January 6, 2021
Share

CDC: Updated interim recommendation for allocation of COVID-19 vaccine

Editor’s Note On December 20, 2020, the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) updated its interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be offered to persons aged 75 years or more and non-healthcare frontline essential workers. In Phase 1c, the vaccine should be…

Read More

By: Judy Mathias
January 5, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat